WASHINGTON, March 1 -- Ardelyx Inc., a biopharmaceutical firm headquartered in Waltham, Massachusetts, has submitted a public comment letter to the Centers for Medicare and Medicaid Services (CMS) expressing strong opposition to the proposed "Guarding U.S. Medicare Against Rising Drug Costs (GUARD) Model." The company warns that importing foreign reference pricing into the United States could have detrimental consequences for small and midsize biopharmaceutical companies, as well as patients rec  more

BOSTON, Massachusetts, Feb. 27 [Category: BizLaw/Legal] -- Goodwin, a law firm, issued the following news release: * * * Goodwin Represents a Consortium of Global Banks on Strategic Equity Investment in OSTTRA * The Private Equity team represented Bank of America, Barclays, Citi, HSBC, UBS Investment Bank, and Wells Fargo on a jointly committed strategic equity investment in OSTTRA, a global post-trade solutions provider. Funds managed by KKR, a leading global investment firm, will continue   more

BOSTON, Massachusetts, Feb. 28 [Category: BizHospital] -- The Dana-Farber Cancer Institute issued the following news release: * * * Kidney Cancer Study Finds Belzutifan Plus Pembrolizumab Post-Surgery Helps Patients at High Risk for Relapse Stay Cancer-Free Longer * Dana-Farber Cancer Institute presents phase 3 LITESPARK-022 data at the 2026 ASCO Genitourinary Cancers Symposium Patients with a common form of kidney cancer called clear cell renal cell carcinoma (ccRCC) who have a high risk  more